Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Nuclear Medicine

Free Subscription Articles published in Nucl Med Commun Retrieve available abstracts of 206 articles: HTML format

Single Articles

July 2025
1. KAPLAN I, Komek H, Can C, Kaya Ipek F, et al
   Effect of body composition parameters, including sarcopenia, myosteatosis, and adipose tissue, on overall survival of patients with mCRPC receiving 177 Lu-PSMA PRRT.
   Nucl Med Commun. 2025;46:592-598.
   PubMed     Abstract available
   
   
   
2. SINGHAL T, Singh P, Parida GK, Agrawal K, et al
   Leg-muscle perfusion reserve on 99mTc-MIBI stress-rest scintigraphy: the novel use of radionuclide imaging in assessing lower extremity functional capacity.
   Nucl Med Commun. 2025;46:599-604.
   PubMed     Abstract available
   
   
   June 2025
3. MOHLAPHOLI MS, Doruyter A, Mix M, Trauernicht C, et al
   The use of simulations to study the effect of acquisition schemes and quantification methods using positron emission tomography: an 18F-Fallypride study.
   Nucl Med Commun. 2025 Jun 6. doi: 10.1097/MNM.0000000000001995.
   PubMed     Abstract available
   
   
   
4. WANG Y, Yang G, Yan W, Yu W, et al
   18 F-FAPI PET/CT in chronic liver disease: myocardial fibroblast activation and its correlates.
   Nucl Med Commun. 2025 Jun 5. doi: 10.1097/MNM.0000000000002002.
   PubMed     Abstract available
   
   
   
5. LEITE E SILVA MH, Barbosa da Silva MA, Dos Santos DSR, Fagundes TC, et al
   PET for predicting chemoradiotherapy survival in cervical cancer: the search continues.
   Nucl Med Commun. 2025 Jun 5. doi: 10.1097/MNM.0000000000001999.
   PubMed     Abstract available
   
   
   
6. MUTEVELIZADE G, Aydin N, Duran Can O, Teke O, et al
   Predicting clinical outcomes using 18F-FDG PET/CT-based radiomic features and machine learning algorithms in patients with esophageal cancer.
   Nucl Med Commun. 2025 Jun 4. doi: 10.1097/MNM.0000000000002003.
   PubMed     Abstract available
   
   
   
7. DESOUZA K, Fessas P, Spurrell E, Papadimitraki E, et al
   The safety and clinical impact of ultra-low-dose FDG-PET imaging in pregnancy-associated breast cancer: the experience of a major tertiary oncology referral centre in the UK and suggested imaging protocol.
   Nucl Med Commun. 2025 Jun 4. doi: 10.1097/MNM.0000000000001997.
   PubMed     Abstract available
   
   
   
8. WANG J, Liu B, Zhang F, Wang J, et al
   The prognostic value of left ventricular diastolic dyssynchrony combined with myocardial perfusion, systolic dyssynchrony, and cardiovascular risk factors in patients with normal left ventricular ejection fraction.
   Nucl Med Commun. 2025;46:545-552.
   PubMed     Abstract available
   
   
   May 2025
9. WANG QC, Cheng MH, Xie LJ
   Semiquantitative analysis of 18F-aluminum fluoride fibroblast activation protein inhibitor 42 PET/computed tomography in primary liver cancer and factors influencing imaging positivity rates.
   Nucl Med Commun. 2025 May 20. doi: 10.1097/MNM.0000000000001994.
   PubMed     Abstract available
   
   
   
10. JUNG KJ, Hong SP, Yoo ID, Lee SM, et al
    Association of quantitative growth plate uptake parameters on bone scintigraphy with growth velocity in children.
    Nucl Med Commun. 2025 May 19. doi: 10.1097/MNM.0000000000001992.
    PubMed     Abstract available
    
    
    
11. WANG Y, Hou M, Zuo T
    Advances in the application of 18F-sodium fluoride PET in the assessment of atherosclerosis.
    Nucl Med Commun. 2025 May 8. doi: 10.1097/MNM.0000000000001988.
    PubMed     Abstract available
    
    
    
12. ABDLKADIR AS, Al-Adhami D, Al Rammahi M, Badarneh M, et al
    Diagnostic pitfalls in [68Ga]Ga-DOTATATE PET/CT imaging: a systematic review.
    Nucl Med Commun. 2025 May 6. doi: 10.1097/MNM.0000000000001987.
    PubMed     Abstract available
    
    
    
13. ALMASLAMANI M, Byun BH, Song K, Kong CB, et al
    PET image nonuniformity texture features for metastasis risk prediction in osteosarcoma.
    Nucl Med Commun. 2025 May 6. doi: 10.1097/MNM.0000000000001989.
    PubMed     Abstract available
    
    
    
14. ZHANG H, Pang L, Hou J, Li B, et al
    Significance of 18F-fluorodeoxyglucose PET/computed tomography in the initial staging of malignant peritoneal mesothelioma.
    Nucl Med Commun. 2025 May 6. doi: 10.1097/MNM.0000000000001990.
    PubMed     Abstract available
    
    
    
15. LENAERTS M, van Amstel FJG, Mottaghy FM, Geurts SME, et al
    A review of the association between baseline [ 18 F] fluorodeoxyglucose uptake and axillary pathological complete response in node-positive breast cancer patients: focus on clinical subtypes.
    Nucl Med Commun. 2025;46:384-391.
    PubMed     Abstract available
    
    
    
16. 
    British Nuclear Medicine Society Spring Meeting 19th-21st May 2025.
    Nucl Med Commun. 2025;46:453-501.
    PubMed    
    
    
    
17. CHEN HY, Tsai YJ, Peng SJ
    Interpretation of basal nuclei in brain dopamine transporter scans using a deep convolutional neural network.
    Nucl Med Commun. 2025;46:418-426.
    PubMed     Abstract available
    
    
    
18. AMINDAROLZARBI A, Satcowitz K, Khalil A, Osman S, et al
    Lack of effect of renal function on uptake of 99m Tc-sestamibi in renal masses.
    Nucl Med Commun. 2025;46:392-395.
    PubMed     Abstract available
    
    
    
19. BONGA KN, Agrawal K, Tripathy SK, Meher BR, et al
    Effectiveness and safety of radionuclide synovectomy with Yttrium-90 hydroxyapatite in patients with inflammatory arthritis: a longitudinal study.
    Nucl Med Commun. 2025;46:396-403.
    PubMed     Abstract available
    
    
    April 2025
20. NISHIMORI M, Iwasa H, Miyatake K, Nitta N, et al
    Correlation between PD-L1 expression and FDG-PET/CT visual assessments in non-small cell lung cancer resected specimens.
    Nucl Med Commun. 2025 Apr 29. doi: 10.1097/MNM.0000000000001984.
    PubMed     Abstract available
    
    
    
21. SAHIN AM, Sen E, Ozkan E, Dursun E, et al
    Thoracic metabolic tumor volume predicts survival in advanced lung adenocarcinoma: a PET/computed tomography-based cohort study.
    Nucl Med Commun. 2025 Apr 23. doi: 10.1097/MNM.0000000000001983.
    PubMed     Abstract available
    
    
    
22. ABDLKADIR AS, Allouzi S, Obeidat S, Mikhail-Lette M, et al
    Exploring utilities of [ 64 Cu]Cu-DOTA-trastuzumab immunoPET in breast cancer: a systematic review and meta-analysis.
    Nucl Med Commun. 2025;46:277-284.
    PubMed     Abstract available
    
    
    
23. CALANDRI E, Verdoia M, Sirovich R, Giraudo MT, et al
    Combined single-photon emission computed tomography-myocardial perfusion imaging with coronary calcium score for assessing coronary disease.
    Nucl Med Commun. 2025;46:317-325.
    PubMed     Abstract available
    
    
    March 2025
24. RIZWAN S, Ayubcha C, Al-Daoud O, Al-Atout M, et al
    PET imaging of atherosclerosis: artificial intelligence applications and recent advancements.
    Nucl Med Commun. 2025 Mar 27. doi: 10.1097/MNM.0000000000001973.
    PubMed     Abstract available
    
    
    
25. USMANI S, Al Riyami K, Ahmed N, Burney IA, et al
    The role of 68Ga-FAPI PET/CT imaging in gynecological cancers: an integrative review.
    Nucl Med Commun. 2025 Mar 25. doi: 10.1097/MNM.0000000000001977.
    PubMed     Abstract available
    
    
    
26. CHEN X, Qi H, Zou Y, Chen Y, et al
    Predicting the spread through air spaces in lung adenocarcinoma from preoperative 18F-FDG PET/CT radiomics.
    Nucl Med Commun. 2025 Mar 18. doi: 10.1097/MNM.0000000000001975.
    PubMed     Abstract available
    
    
    
27. PENG M, Yang X, Wang Y, Zhou L, et al
    Clinical combined PET/CT radiomics model prediction of benefit from platinum-based chemotherapy and chemoradiotherapy in patients with small cell lung cancer.
    Nucl Med Commun. 2025 Mar 14. doi: 10.1097/MNM.0000000000001971.
    PubMed     Abstract available
    
    
    
28. ZHANG R, Zhang X, Gao Q, Zhang H, et al
    Prognostic significance of total metabolic tumor volume on baseline 18F-FDG PET/CT in patients with lung adenocarcinoma: further stratification of the ninth edition of TNM staging subgroups.
    Nucl Med Commun. 2025 Mar 14. doi: 10.1097/MNM.0000000000001976.
    PubMed     Abstract available
    
    
    
29. BROWN S, Kwok F, Evans S, Geenty P, et al
    99mTechnetium-pyrophosphate SPECT/CT with novel semiautomated quantification has excellent diagnostic accuracy for detecting cardiac transthyretin amyloidosis.
    Nucl Med Commun. 2025 Mar 12. doi: 10.1097/MNM.0000000000001972.
    PubMed     Abstract available
    
    
    
30. STROBEL K, Grunig H, Lima T, Bartschi D, et al
    Comparison of reprojected 'pseudoplanar' bone SPECT/CT and planar bone scintigraphy for the detection and localization of foot and ankle osteoarthritis.
    Nucl Med Commun. 2025 Mar 12. doi: 10.1097/MNM.0000000000001974.
    PubMed     Abstract available
    
    
    
31. KIMOTO H, Owaki Y, Minamishima K, Inoue K, et al
    Optimization of imaging conditions for technetium-99m dimercaptosuccinic acid single photon emission computed tomography examinations in neonates.
    Nucl Med Commun. 2025 Mar 3. doi: 10.1097/MNM.0000000000001962.
    PubMed     Abstract available
    
    
    
32. TOYAMA T, Kasama S, Sato M, Sano H, et al
    The most important prognostic factors for predicting major adverse cardiovascular, cerebrovascular, and renal events during 5-year follow-up of patients with chronic kidney disease with or without haemodialysis.
    Nucl Med Commun. 2025;46:223-229.
    PubMed     Abstract available
    
    
    
33. SUBRAMANYAM P, Palaniswamy SS
    18 F-FDG metabolic abnormalities precede perfusion and atrophic changes in diagnosis of early frontotemporal dementia: study from a tertiary care university hospital.
    Nucl Med Commun. 2025;46:248-259.
    PubMed     Abstract available
    
    
    February 2025
34. GEMMELL AJ, Brown CM, Ray S, Small A, et al
    Comparison of quantitative Krenning Scores with visual assessment in 99mTc-EDDA/HYNIC-TOC SPECT-CT.
    Nucl Med Commun. 2025 Feb 27. doi: 10.1097/MNM.0000000000001967.
    PubMed     Abstract available
    
    
    
35. YAMAKUNI R, Ishii S, Fukushima K, Kakamu T, et al
    Comparison of visual interpretation of [I-123] FP-CIT SPECT scans versus reference-based quantitative analysis utilizing a Japanese normal database.
    Nucl Med Commun. 2025 Feb 25. doi: 10.1097/MNM.0000000000001968.
    PubMed     Abstract available
    
    
    
36. KAPLAN I, Yeprem O, Komek H, Kepenek F, et al
    Contribution of tubarial salivary gland function detected through 68Ga-prostate-specific membrane antigen PET/computed tomography to total salivary gland function.
    Nucl Med Commun. 2025 Feb 25. doi: 10.1097/MNM.0000000000001970.
    PubMed     Abstract available
    
    
    
37. GUO C, Luo J, Liang M, Xiao J, et al
    Correlation of 18F-FDG PET/CT metabolic parameters with Ki-67 expression and tumor staging in nasopharyngeal carcinoma.
    Nucl Med Commun. 2025 Feb 19. doi: 10.1097/MNM.0000000000001966.
    PubMed     Abstract available
    
    
    
38. RUAN X, Zhang B, Chen Z, Wu H, et al
    Improved grading method of 99mTc-dimercaptosuccinic acid static renal imaging helps predict the prognosis of urinary tract infection in children.
    Nucl Med Commun. 2025 Feb 14. doi: 10.1097/MNM.0000000000001961.
    PubMed     Abstract available
    
    
    
39. HUANG M, Wang Y, Yang X, Li N, et al
    Establishing a threshold for maximum standardized uptake value on 18F-fluorodeoxyglucose PET/CT to predict high-grade lung adenocarcinoma and its prognostic significance.
    Nucl Med Commun. 2025 Feb 12. doi: 10.1097/MNM.0000000000001959.
    PubMed     Abstract available
    
    
    
40. FRASER L, Parkar N, Powell A, Richardson M, et al
    Interpretation and implementation of adult diagnostic reference levels in nuclear medicine and positron emission tomography in the UK.
    Nucl Med Commun. 2025 Feb 5. doi: 10.1097/MNM.0000000000001953.
    PubMed     Abstract available
    
    
    
41. LI LL, Wang L, Li HW, Chen H, et al
    Utility of preoperative 18F-flurodeoxyglucose PET/CT scanning in preoperative evaluation and surgical planning for pulmonary tuberculosis.
    Nucl Med Commun. 2025;46:180-186.
    PubMed     Abstract available
    
    
    
42. RICE SL, Munoz FG, Benjamin JL, Alnablsi MW, et al
    Local and systemic biodistribution of a small-molecule radiopharmaceutical probe after transcatheter embolization and intra-arterial delivery in a porcine orthotopic renal tumor model.
    Nucl Med Commun. 2025;46:138-145.
    PubMed     Abstract available
    
    
    
43. LU C, Yu Y, Wang S, Yin X, et al
    The application of extraocular muscle maximum standardized uptake value of 99mTc-diethylenetriamine pentaacetic acid orbital single photon emission computed tomography/computed tomography in the assessment of Graves' orbitopathy.
    Nucl Med Commun. 2025;46:120-127.
    PubMed     Abstract available
    
    
    
44. ROSE DS, Hector BM, Kannan S, Lee JC, et al
    Sublingual glyceryl trinitrate given during adenosine sestamibi myocardial perfusion imaging causes apparent transient ischaemic dilation in a propensity-matched analysis.
    Nucl Med Commun. 2025;46:128-137.
    PubMed     Abstract available
    
    
    January 2025
45. STEPIEN-WRONIECKA A, Dziewiecka E, Graczyk K, Holcman K, et al
    Gated myocardial perfusion SPECT for evaluating left ventricular dyssynchrony in cardiac resynchronization therapy candidates: a systematic review.
    Nucl Med Commun. 2025 Jan 24. doi: 10.1097/MNM.0000000000001955.
    PubMed     Abstract available
    
    
    
46. SU S, Wang G, Ye X, Wang H, et al
    The role of 18F-FDG PET/CT in detecting recurrence and metastasis in posttreatment nasopharyngeal carcinoma patients with elevated Epstein-Barr virus DNA.
    Nucl Med Commun. 2025 Jan 22. doi: 10.1097/MNM.0000000000001954.
    PubMed     Abstract available
    
    
    
47. HU N, Yan G, Tang M, Yuan S, et al
    Prognostic value of serum cholinesterase and 18F-FDG PET/CT-derived metabolic parameters in non-small cell lung cancer patients: a retrospective cohort study.
    Nucl Med Commun. 2025 Jan 21. doi: 10.1097/MNM.0000000000001952.
    PubMed     Abstract available
    
    
    
48. TING M, McDermott G, Zarei A, Patel C, et al
    Qualitative and quantitative analysis of reduced bed position acquisition time on FDG PET image quality.
    Nucl Med Commun. 2025 Jan 21. doi: 10.1097/MNM.0000000000001957.
    PubMed     Abstract available
    
    
    
49. LI M, Liu J, Lv R, Liu F, et al
    Network topology and metabolic alterations in early- and mid-stage Parkinson's disease: insights from fluorodeoxyglucose PET imaging.
    Nucl Med Commun. 2025 Jan 20. doi: 10.1097/MNM.0000000000001951.
    PubMed     Abstract available
    
    
    
50. FAN Y, Liu Y, Ouyang X, Su J, et al
    Prediction of EGFR mutation status and its subtypes in non-small cell lung cancer based on 18F-FDG PET/CT radiological features.
    Nucl Med Commun. 2025 Jan 20. doi: 10.1097/MNM.0000000000001948.
    PubMed     Abstract available
    
    
    
51. ROMERO-FARINA G, Aguade-Bruix S, Ferreira-Gonzalez I
    Different degrees of summed difference perfusion score in women: influence on the prognostic variables associated with cardiac events.
    Nucl Med Commun. 2025;46:28-37.
    PubMed     Abstract available
    
    
    
52. VILJAMAA HR, Ripatti LLM, Larjava HRS, Noponen TEJ, et al
    Radiation exposure in vesicoureteral reflux diagnostics: a comparative study of direct radionuclide cystography and voiding cystourethrogram.
    Nucl Med Commun. 2025;46:15-20.
    PubMed     Abstract available
    
    
    
53. ZHANG M, Sun Y, Zhang L, Xu Y, et al
    The application of mass defect percentage in the evaluation of acute coronary syndrome.
    Nucl Med Commun. 2025;46:1-6.
    PubMed     Abstract available
    
    
    
54. BURTON L, Khoma O, Gooley S, Falk GL, et al
    Solid versus liquid pulmonary micro-aspiration of reflux disease. Does it make a difference in determining the need for intervention?
    Nucl Med Commun. 2025;46:7-14.
    PubMed     Abstract available
    
    
    December 2024
55. TOYLI A, Hung GU, Zhao C, Sha Q, et al
    Comparison of cerebral technetium-99m-ethyl cysteinate dimer perfusion in patients with dementia with Lewy bodies and Parkinson's disease dementia.
    Nucl Med Commun. 2024 Dec 23. doi: 10.1097/MNM.0000000000001946.
    PubMed     Abstract available
    
    
    
56. JAIN B, Khandelwal Y, Ora M, Mishra P, et al
    Metabolic markers derived from 18F-FDG PET/CT in suspected recurrent ovarian carcinoma: predictive value for disease burden and prognosis.
    Nucl Med Commun. 2024 Dec 17. doi: 10.1097/MNM.0000000000001944.
    PubMed     Abstract available
    
    
    
57. SARIKAYA I
    Radionuclide treatments of cancer: molecular mechanisms, biological responses, histopathological changes, and role of PET imaging.
    Nucl Med Commun. 2024 Dec 10. doi: 10.1097/MNM.0000000000001941.
    PubMed     Abstract available
    
    
    
58. CHEN Y, Zhang Q, Hu Y, Liu E, et al
    Semiquantitative muscle parameters derived from FAPI and FDG PET/CT in evaluating sarcopenia among patients with malignant tumors.
    Nucl Med Commun. 2024 Dec 9. doi: 10.1097/MNM.0000000000001945.
    PubMed     Abstract available
    
    
    
59. PANDIT-TASKAR N, Basu E, Balquin E, Mozley PD, et al
    Safety observations in neuroblastoma patients undergoing 18F-mFBG PET.
    Nucl Med Commun. 2024 Dec 6. doi: 10.1097/MNM.0000000000001938.
    PubMed     Abstract available
    
    
    
60. ASKARI E, Saidi B, Evangelista L
    Indications for diagnostic whole-body iodine scan: a review of guidelines.
    Nucl Med Commun. 2024;45:998-1006.
    PubMed     Abstract available
    
    
    
61. ANTON FARIA R, Chagas Jaguar G, Nobrega Pereira Lima E
    Parametric imaging in salivary gland scintigraphy.
    Nucl Med Commun. 2024;45:1098-1104.
    PubMed     Abstract available
    
    
    November 2024
62. OZKAN E, Unal S, Akkus P, Peker E, et al
    Diagnostic performance of fluorine-18-fluorodeoxyglucose PET/MRI for detection of disease recurrence in differentiated thyroid cancer: a compartment-based analysis.
    Nucl Med Commun. 2024 Nov 28. doi: 10.1097/MNM.0000000000001937.
    PubMed     Abstract available
    
    
    
63. YIN P, Maliha PG, Ebrahim A, Ben-Ezra N, et al
    Variants of physiological FDG vascular activity on digital PET.
    Nucl Med Commun. 2024 Nov 28. doi: 10.1097/MNM.0000000000001935.
    PubMed     Abstract available
    
    
    
64. LEE D, Green J, Crane J, Taylor DR, et al
    Adrenal oncocytoma: a rare presentation of a benign 18F-fluorodeoxyglucose PET avid virilising adrenal tumour.
    Nucl Med Commun. 2024 Nov 28. doi: 10.1097/MNM.0000000000001932.
    PubMed     Abstract available
    
    
    
65. LUO Y, Li X, Sun J, Liu S, et al
    Predicting higher-risk growth patterns in invasive lung adenocarcinoma with multiphase multidetector computed tomography and 18F-fluorodeoxyglucose PET radiomics.
    Nucl Med Commun. 2024 Nov 21. doi: 10.1097/MNM.0000000000001931.
    PubMed     Abstract available
    
    
    
66. KESIM S, Turoglu HT, Kotan T, Balaban Genc ZC, et al
    Efficacy of additional lateral pinhole and SPECT/CT imaging in dual-phase Tc-99m MIBI parathyroid scintigraphy for localising parathyroid pathologies in patients with primary hyperparathyroidism: a single-institution experience.
    Nucl Med Commun. 2024 Nov 8. doi: 10.1097/MNM.0000000000001924.
    PubMed     Abstract available
    
    
    
67. WANG F, Chen Y, Tan X, Han X, et al
    PET/computed tomography radiomics combined with clinical features in predicting sarcopenia and prognosis of diffuse large B-cell lymphoma.
    Nucl Med Commun. 2024 Nov 5. doi: 10.1097/MNM.0000000000001925.
    PubMed     Abstract available
    
    
    
68. TAKESHI N, Shota H, Tomoya K, Yasunori N, et al
    Image reconstruction parameters and the standardized uptake value ratios in brain amyloid PET.
    Nucl Med Commun. 2024;45:984-991.
    PubMed     Abstract available
    
    
    
69. VOO S, Baldeweg SE, Kumar R, Singh H, et al
    Perennial inconsistencies and lack of evidence-based recommendations in current guidelines addressing blood glucose level regulations for optimal 18F-fluorodeoxyglucose PET imaging: 25-year 'silver jubilee' of an ongoing unsolved problem in nuclear me
    Nucl Med Commun. 2024;45:897-900.
    PubMed    
    
    
    
70. HASEGAWA D, Iguchi T, Takatani M, Tokunaga K, et al
    Effect of single-photon emission computed tomography acquisition method and sampling angles on image quality and quantitative accuracy in xSPECT-reconstructed images.
    Nucl Med Commun. 2024;45:916-923.
    PubMed     Abstract available
    
    
    
71. GRUNIG H, Strobel K, Zander A, Perez Lago MDS, et al
    Significance of incidental thyroid 18 F-fluorocholine uptake in patients with hyperparathyroidism imaged for localizing hyperfunctioning parathyroid glands.
    Nucl Med Commun. 2024;45:938-946.
    PubMed     Abstract available
    
    
    October 2024
72. VAN DER ZANT FM, Wondergem M, Broos WAM, Lazarenko SV, et al
    Frequency and characteristics of ectopic parathyroid adenomas in a cohort of patients referred for 18F-fluorocholine PET/CT.
    Nucl Med Commun. 2024 Oct 22. doi: 10.1097/MNM.0000000000001920.
    PubMed     Abstract available
    
    
    
73. STOFFELS M, Cousin F, Lamande M, Denis C, et al
    Characterization of exclusive rib lesions detected by [68Ga]Ga-PSMA-11 PET/CT.
    Nucl Med Commun. 2024 Oct 21. doi: 10.1097/MNM.0000000000001919.
    PubMed     Abstract available
    
    
    
74. OZMAN O, Veerman H, Hagens MJ, van Leeuwen PJ, et al
    The effect of PSMA PET/CT on clinical decision-making of radical prostatectomy and pelvic lymph node dissection.
    Nucl Med Commun. 2024 Oct 17. doi: 10.1097/MNM.0000000000001916.
    PubMed     Abstract available
    
    
    
75. MURRAY AW, Scuffham JW, Dickson JC, Memmott M, et al
    UK national survey on nuclear medicine in-house clinical software: the calm before the storm.
    Nucl Med Commun. 2024 Oct 16. doi: 10.1097/MNM.0000000000001917.
    PubMed     Abstract available
    
    
    
76. JIANG C, Zhao M, Zhang W
    Application of 18F-fluorodeoxyglucose PET/computed tomography in the diagnosis of infiltrative subsolid nodules in lung adenocarcinoma.
    Nucl Med Commun. 2024 Oct 16. doi: 10.1097/MNM.0000000000001908.
    PubMed     Abstract available
    
    
    
77. JIA Q, Wang A, Liu Y, Fan Y, et al
    Diagnostic value of baseline 18F-FDG PET/CT and peripheral blood inflammatory markers for aggressive lymphoma in non-Hodgkin's lymphoma.
    Nucl Med Commun. 2024 Oct 15. doi: 10.1097/MNM.0000000000001912.
    PubMed     Abstract available
    
    
    
78. ORTEGA C, Anconina R, Joshi S, Metser U, et al
    Combination of FDG PET/CT radiomics and clinical parameters for outcome prediction in patients with non-Hodgkin's lymphoma.
    Nucl Med Commun. 2024 Oct 15. doi: 10.1097/MNM.0000000000001895.
    PubMed     Abstract available
    
    
    
79. YANG S, Ma R, Wu J
    The diagnostic value of combining preoperative serum CA19-9, ALBI score, and 18F-FDG PET/CT imaging in preoperative resectability of pancreatic cancer.
    Nucl Med Commun. 2024 Oct 4. doi: 10.1097/MNM.0000000000001910.
    PubMed     Abstract available
    
    
    
80. MU X, Lu L, Li J, Zhang L, et al
    Low false-positive lymph nodes for 18F-fibroblast activation protein inhibitors PET/computed tomography in preoperative staging of patients with nonsmall cell lung cancer.
    Nucl Med Commun. 2024 Oct 4. doi: 10.1097/MNM.0000000000001913.
    PubMed     Abstract available
    
    
    
81. KARAOGLAN H, Kepenek F, Komek H, Kaplan I, et al
    The prognostic role of whole-body volumetric positron emission tomography/computed tomography parameters in treatment naive colorectal cancer patients with liver metastases.
    Nucl Med Commun. 2024 Oct 2. doi: 10.1097/MNM.0000000000001915.
    PubMed     Abstract available
    
    
    
82. LI J, Cui N, Wang Y, Li W, et al
    Prediction of preoperative lymph-vascular space invasion and survival outcomes of cervical squamous cell carcinoma by utilizing 18F-FDG PET/CT imaging at early stage.
    Nucl Med Commun. 2024 Oct 2. doi: 10.1097/MNM.0000000000001909.
    PubMed     Abstract available
    
    
    
83. SEN AE, Kaya B, Bozcuk HS, Sahin O, et al
    Evaluation of brain metabolism using F18-FDG PET/CT imaging in patients diagnosed with lung cancer.
    Nucl Med Commun. 2024 Oct 2. doi: 10.1097/MNM.0000000000001911.
    PubMed     Abstract available
    
    
    
84. KOTE R, Ravina M, Goyal H, Mohanty D, et al
    Role of textural and radiomic analysis parameters in predicting histopathological parameters of the tumor in breast cancer patients.
    Nucl Med Commun. 2024;45:835-847.
    PubMed     Abstract available
    
    
    
85. ULRICH M, Lehnick D, Strobel K, Grunig H, et al
    Quantitative bone single photon emission computed tomography/computed tomography in symptomatic and asymptomatic foot and ankle osteoarthritis.
    Nucl Med Commun. 2024;45:848-857.
    PubMed     Abstract available
    
    
    September 2024
86. AN EJ, Kim JB, Son J, Jeong SY, et al
    Deep learning-based binary classification of beta-amyloid plaques using 18F florapronol PET.
    Nucl Med Commun. 2024 Sep 27. doi: 10.1097/MNM.0000000000001904.
    PubMed     Abstract available
    
    
    
87. PALANISWAMY SS, Subramanyam P
    Diagnostic performance of simultaneous PET-magnetic resonance versus PET-computed tomography in oncology with an overview on clinical utility and referral pattern of PET-magnetic resonance: a single institutional study.
    Nucl Med Commun. 2024 Sep 26. doi: 10.1097/MNM.0000000000001900.
    PubMed     Abstract available
    
    
    
88. WANG X, Yang C, Wang X, Wang D, et al
    Predicting invasiveness of ground-glass nodules in lung adenocarcinoma: based on preoperative 18F-fluorodeoxyglucose PET/computed tomography and high-resolution computed tomography.
    Nucl Med Commun. 2024 Sep 18. doi: 10.1097/MNM.0000000000001898.
    PubMed     Abstract available
    
    
    
89. WU F, Cao G, Lu J, Ye S, et al
    Correlation between 18F-FDG PET/CT metabolic parameters and microvascular invasion before liver transplantation in patients with hepatocellular carcinoma.
    Nucl Med Commun. 2024 Sep 13. doi: 10.1097/MNM.0000000000001897.
    PubMed     Abstract available
    
    
    
90. ZEYDAN B, Johnson DR, Schwarz CG, Przybelski SA, et al
    Visual assessments of 11C-Pittsburgh compound-B PET vs. 18F-flutemetamol PET across the age spectrum.
    Nucl Med Commun. 2024 Sep 13. doi: 10.1097/MNM.0000000000001902.
    PubMed     Abstract available
    
    
    
91. SHIRAI A, Ogura I
    Evaluation of jaw pathologies of patients with medication-related osteonecrosis of the jaw using a computer program to assess the bone scan index: comparison of standardized uptake values with bone SPECT/CT.
    Nucl Med Commun. 2024 Sep 12. doi: 10.1097/MNM.0000000000001896.
    PubMed     Abstract available
    
    
    
92. DORRI GIV M, Arabi H, Naseri S, Alipour Firouzabad L, et al
    Evaluation of the prostate cancer and its metastases in the [68Ga]Ga-PSMA PET/CT images: deep learning method vs. conventional PET/CT processing.
    Nucl Med Commun. 2024 Sep 3. doi: 10.1097/MNM.0000000000001891.
    PubMed     Abstract available
    
    
    
93. IZADI MA, Alemohammad N, Geramifar P, Salimi A, et al
    Automatic detection and segmentation of lesions in 18F-FDG PET/CT imaging of patients with Hodgkin lymphoma using 3D dense U-Net.
    Nucl Med Commun. 2024 Sep 3. doi: 10.1097/MNM.0000000000001892.
    PubMed     Abstract available
    
    
    August 2024
94. NASR H, Alnajashi N, Farghaly H, Alqarni A, et al
    18F FDG PET/CT versus 99m Tc MDP Bone scintigraphy in imaging of metastatic osseous disease in breast cancer patients; Solving the discrepancies in light of serum markers.
    Nucl Med Commun. 2024 Aug 22. doi: 10.1097/MNM.0000000000001888.
    PubMed     Abstract available
    
    
    
95. LEE I, Byun BH, Kim BI, Choi CW, et al
    Evaluating 64Cu-DOTA-rituximab as a PET agent in patients with B-cell lymphoma: a head-to-head comparison with 18F-fluorodeoxyglucose PET/computed tomography.
    Nucl Med Commun. 2024 Aug 19. doi: 10.1097/MNM.0000000000001889.
    PubMed     Abstract available
    
    
    
96. BIBEAU-DELISLE A, Bouabdallaoui N, Lamarche C, Harel F, et al
    Assessment of renal perfusion with 82-rubidium PET in patients with normal and abnormal renal function.
    Nucl Med Commun. 2024 Aug 19. doi: 10.1097/MNM.0000000000001890.
    PubMed     Abstract available
    
    
    
97. LANG J, Liu W, Liu G, Liu S, et al
    Prognostic value of 18F-FDG PET/CT in postoperative recurrence of retroperitoneal liposarcoma: a single-center retrospective study.
    Nucl Med Commun. 2024 Aug 8. doi: 10.1097/MNM.0000000000001886.
    PubMed     Abstract available
    
    
    
98. CZIBOR S, Csatlos Z, Fabian K, Piroska M, et al
    Volumetric and textural analysis of PET/CT in patients with diffuse large B-cell lymphoma highlights the importance of novel MTVrate feature.
    Nucl Med Commun. 2024 Aug 2. doi: 10.1097/MNM.0000000000001884.
    PubMed     Abstract available
    
    
    
99. GUO L, Wang R, Shen G
    Fluorine-18 fluorodeoxyglucose uptake change in liver, mediastinal blood pool, and lymphoid cell-rich organs during programmed cell death-1 immunotherapy in lymphoma.
    Nucl Med Commun. 2024;45:718-726.
    PubMed     Abstract available
    
    
    July 2024
100. FRAGKIADAKI V, Panagiotidis E, Vlontzou E, Kalathas T, et al
     Correlation of PSA blood levels with standard uptake value maximum (SUVmax) and total metabolic tumor volume (TMTV) in 18F-PSMA-1007 and 18F-choline PET/CT in patients with biochemically recurrent prostate cancer.
     Nucl Med Commun. 2024 Jul 30. doi: 10.1097/MNM.0000000000001881.
     PubMed     Abstract available
     
     
     
101. KALSHETTY A, Nazar A, Vimalnath KV, Chakravarty R, et al
     [64Cu]Copper chloride PET-CT: a comparative evaluation of fasting and non-fasting states in patients of prostate carcinoma.
     Nucl Med Commun. 2024 Jul 30. doi: 10.1097/MNM.0000000000001882.
     PubMed     Abstract available
     
     
     
102. USMANI S, Al Riyami K, Jain A, Alajmi AA, et al
     Enhancing precision in bone metastasis diagnosis for lobular breast cancer: reassessing the role of 18F-FDG PET/CT.
     Nucl Med Commun. 2024 Jul 22. doi: 10.1097/MNM.0000000000001880.
     PubMed     Abstract available
     
     
     
103. NOTGHI A
     Dr. Leslie Keith Harding (3 February 1939 - 14 September 2023).
     Nucl Med Commun. 2024;45:650.
     PubMed    
     
     
     
104. ERDOGAN EB, Tekce E, Koca S, Aslan N, et al
     Predictive significance of intraprostatic volumetric parameters derived from early and standard time 68Ga-PSMA PET/CT images in newly diagnosed prostate cancer patients.
     Nucl Med Commun. 2024;45:629-641.
     PubMed     Abstract available
     
     
     
105. ALONGI P, Messina M, Pepe A, Arnone A, et al
     Prostate-specific membrane antigen-PET/CT may result in stage migration in prostate cancer: performances, quantitative analysis, and potential criticism in the clinical practice.
     Nucl Med Commun. 2024;45:622-628.
     PubMed     Abstract available
     
     
     
106. NOTGHI A, James G, O'Brien J, Arasaradnam R, et al
     British Nuclear Medicine Society SeHCAT guidelines.
     Nucl Med Commun. 2024;45:564-572.
     PubMed    
     
     
     
107. ISHII S, Sugawara S, Tanaka Y, Kawamoto N, et al
     Impact of iodine contrast media on gamma camera-based GFR and factors affecting the difference between serum creatinine-based estimated GFR and Gate's GFR.
     Nucl Med Commun. 2024;45:573-580.
     PubMed     Abstract available
     
     
     June 2024
108. LITTLE D, Graham R, Redman S
     BNMS guidelines for Nuclear Medicine Events and Learning Meetings: principles for departmental learning from unforeseen events.
     Nucl Med Commun. 2024 Jun 27. doi: 10.1097/MNM.0000000000001876.
     PubMed    
     
     
     
109. CHANDEKAR KR, Satapathy S, Singh H, Kumar R, et al
     Utility of PSMA-PET derived volumetric parameters in initial risk stratification and prediction of prostate cancer metastasis - a head-to-head comparison of the radiotracers 18F-PSMA-1007 and 68Ga-PSMA-11.
     Nucl Med Commun. 2024 Jun 27. doi: 10.1097/MNM.0000000000001874.
     PubMed     Abstract available
     
     
     
110. PETERS AM
     The physiological basis of renal nuclear medicine.
     Nucl Med Commun. 2024 Jun 21. doi: 10.1097/MNM.0000000000001872.
     PubMed     Abstract available
     
     
     
111. MOHEBBI A, Kiani I, Mohammadzadeh S, Mirza-Aghazadeh-Attari M, et al
     Enhanced staging of extrahepatic hepatocellular carcinoma metastasis through dual-tracer PET/computed tomography: a systematic review and meta-analysis.
     Nucl Med Commun. 2024 Jun 19. doi: 10.1097/MNM.0000000000001870.
     PubMed     Abstract available
     
     
     
112. ALENEZI S, Dannoon S, Alnafisi N, Elgazzar A, et al
     Hyperostosis frontalis interna on fluorine-18 sodium fluoride PET/computed tomography of obese cancer patients: a potential mimicker of metastasis.
     Nucl Med Commun. 2024 Jun 14. doi: 10.1097/MNM.0000000000001873.
     PubMed     Abstract available
     
     
     
113. MLV SK, Mittal R, Chauhan N, Kumar R, et al
     Evaluation of the metabolic activity of the torn rotator cuff muscles by 18F-2-deoxy-d-glucose PET-computed tomography scan.
     Nucl Med Commun. 2024 Jun 14. doi: 10.1097/MNM.0000000000001871.
     PubMed     Abstract available
     
     
     
114. SONAVANE S, Salvi O, Asopa RV, Basu S, et al
     Assessing Krenning's score on 68Ga-DOTATATE PET-CT and miPSMA score on 68Ga-PSMA-11 PET-CT in TENIS: a comparison with FDG PET/CT and examining the feasibility of targeted radionuclide therapy.
     Nucl Med Commun. 2024 Jun 3. doi: 10.1097/MNM.0000000000001856.
     PubMed     Abstract available
     
     
     
115. PANAGIOTIDIS E, Andreou S, Paschali A, Angeioplasti K, et al
     Towards improved diagnosis: radiomics and quantitative biomarkers in 18F-PSMA-1007 and 18F-fluorocholine PET/CT for prostate cancer recurrence.
     Nucl Med Commun. 2024 Jun 3. doi: 10.1097/MNM.0000000000001867.
     PubMed     Abstract available
     
     
     
116. IDE BOLET S, Sisti J, Cheng K, Dadparvar S, et al
     Quantitative Lobar Tc99m-MAA SPECT/CT of the Lung in pre-and post-procedural guidance for Bronchoscopic Lung Volume Reduction.
     Nucl Med Commun. 2024 Jun 3. doi: 10.1097/MNM.0000000000001868.
     PubMed     Abstract available
     
     
     
117. SCUFFHAM JW, Dickson JC, Murray A, Flux GD, et al
     Commentary on the current status of nuclear medicine medical physics expert support in the UK.
     Nucl Med Commun. 2024;45:541-545.
     PubMed    
     
     
     
118. WICKS S, Levart D, Conway L, Heraghty N, et al
     Noninvasive measurement of tracer extraction efficiency in tissue, illustrated with Tc-99m-MAG3.
     Nucl Med Commun. 2024;45:519-525.
     PubMed     Abstract available
     
     
     
119. ADIN ME, Isufi E, Wu J, Pang Y, et al
     Reactive axillary lymph nodes after COVID-19 mRNA vaccination: comparison of mRNA vs. attenuated whole-virus vaccines.
     Nucl Med Commun. 2024;45:474-480.
     PubMed     Abstract available
     
     
     
120. DILAWAR H, Habib S, Rana R, Ahmed A, et al
     Comparison of absolute renal uptake by using Tc-99m MAG-3 and Tc-99m DMSA.
     Nucl Med Commun. 2024;45:481-486.
     PubMed     Abstract available
     
     
     May 2024
121. HU Y, Guo D, Zhu Z, Lu L, et al
     The value of dual time-point fluorine-18 fluorodeoxyglucose PET/computed tomography imaging in predicting lymph node metastasis in non-small cell lung cancer patients.
     Nucl Med Commun. 2024 May 27. doi: 10.1097/MNM.0000000000001866.
     PubMed     Abstract available
     
     
     
122. SPILIOTOPOULOU M, Papathanasiou N, Labieniec L, Papachristou E, et al
     99mTc-DTPA dynamic SPECT/CT renogram in adults: feasibility and diagnostic benefit.
     Nucl Med Commun. 2024 May 23. doi: 10.1097/MNM.0000000000001865.
     PubMed     Abstract available
     
     
     
123. MITITELU R, Mitoi A, Mazilu C, Jinga M, et al
     Advancements in hepatocellular carcinoma management: the role of 18F-FDG PET-CT in diagnosing portal vein tumor thrombosis.
     Nucl Med Commun. 2024 May 17. doi: 10.1097/MNM.0000000000001863.
     PubMed     Abstract available
     
     
     
124. KHAN D, Phulia A, Kumar S, Sarswat S, et al
     Role of 18F-FDG PET/CT for providing a targeted approach for etiology of PUO.
     Nucl Med Commun. 2024 May 17. doi: 10.1097/MNM.0000000000001855.
     PubMed     Abstract available
     
     
     
125. PAN Q, Cao X, Li J, Li F, et al
     Different extramedullary disease shown in chemokine receptor 4 targeted PET/CT with [68Ga]Ga-pentixafor in patients with Waldenstrom macroglobulinemia and smoldering disease.
     Nucl Med Commun. 2024 May 15. doi: 10.1097/MNM.0000000000001862.
     PubMed     Abstract available
     
     
     
126. FILIZOGLU N, Ozguven S, Akin Telli T, Ones T, et al
     Defining the optimal segmentation method for measuring somatostatin receptor expressing tumor volume on 68Ga-DOTATATE positron emission tomography/computed tomography to predict prognosis in patients with gastroenteropancreatic neuroendocrine tumors.
     Nucl Med Commun. 2024 May 15. doi: 10.1097/MNM.0000000000001861.
     PubMed     Abstract available
     
     
     
127. PEIX A, Jimenez-Heffernan A, Devasenapathy N, Sobic-Saranovic D, et al
     Correlates of markers of dyssynchrony in patients with STEMI and multivessel disease: an analysis from the IAEA SPECT STEMI trial.
     Nucl Med Commun. 2024 May 15. doi: 10.1097/MNM.0000000000001860.
     PubMed     Abstract available
     
     
     
128. LAU JHY, Ng KK, Wong WC, Ng KS, et al
     Retrospective study of qualitative assessment in detecting synchronous and metachronous malignancies in adult cancer patients by 18F-FDG PET/CT.
     Nucl Med Commun. 2024 May 10. doi: 10.1097/MNM.0000000000001857.
     PubMed     Abstract available
     
     
     
129. 
     British Nuclear Medicine Society Spring Meeting 13th - 15th May 2024.
     Nucl Med Commun. 2024;45:420-461.
     PubMed    
     
     
     
130. KIAN ARA H, Alemohammad N, Paymani Z, Ebrahimi M, et al
     Machine learning diagnosis of active Juvenile Idiopathic Arthritis on blood pool [ 99M Tc] Tc-MDP scintigraphy images.
     Nucl Med Commun. 2024;45:355-361.
     PubMed     Abstract available
     
     
     April 2024
131. JAIN Y, Agrawal A, Joshi A, Menon S, et al
     Can 18F FDG PET/CT metabolic parameters be used to noninvasively differentiate between different histopathological subtypes and Fuhrman grades of renal cell cancer?
     Nucl Med Commun. 2024 Apr 30. doi: 10.1097/MNM.0000000000001844.
     PubMed     Abstract available
     
     
     
132. WANG B, Zhao X, Liu Y, Zhang Z, et al
     Comparison of 68Ga-FAPI-04 PET/CT with 18F-FDG PET/CT for diagnosis and staging of gastric and colorectal cancer.
     Nucl Med Commun. 2024 Apr 29. doi: 10.1097/MNM.0000000000001845.
     PubMed     Abstract available
     
     
     
133. AL-IBRAHEEM A, Allouzi S, Abdlkadir AS, Mikhail-Lette M, et al
     PET/CT in leukemia: utility and future directions.
     Nucl Med Commun. 2024 Apr 22. doi: 10.1097/MNM.0000000000001846.
     PubMed     Abstract available
     
     
     
134. BESTETTI A, Zangheri B, Gabanelli SV, Parini V, et al
     Union is strength: the combination of radiomics features and 3D-deep learning in a sole model increases diagnostic accuracy in demented patients: a whole brain 18FDG PET-CT analysis.
     Nucl Med Commun. 2024 Apr 18. doi: 10.1097/MNM.0000000000001853.
     PubMed     Abstract available
     
     
     
135. MUT F, Gaudiano MP, Kapitan M
     Relationship between transient ischemic dilatation and changes in heart rate during gated SPECT acquisition in a low-risk population without perfusion defects.
     Nucl Med Commun. 2024 Apr 15. doi: 10.1097/MNM.0000000000001852.
     PubMed     Abstract available
     
     
     
136. SAXENA A, Subramanyam P, Sarma M, Bhad B, et al
     18F-FDG PET imaging for treatment response assessment and management guidance in patients with skull base osteomyelitis.
     Nucl Med Commun. 2024 Apr 15. doi: 10.1097/MNM.0000000000001847.
     PubMed     Abstract available
     
     
     
137. KUMAR P, Arora P, Kumar R, Singh H, et al
     Evaluation of skull bone viability and effect of early surgical intervention in electrical contact burns using 18F-Sodium Fluoride PET-CT imaging.
     Nucl Med Commun. 2024 Apr 9. doi: 10.1097/MNM.0000000000001842.
     PubMed     Abstract available
     
     
     
138. 
     Role of textural analysis parameters derived from FDG PET/CT in differentiating hepatocellular carcinoma and hepatic metastases: Erratum.
     Nucl Med Commun. 2024;45:353.
     PubMed    
     
     
     
139. GIBBONS T, Perkins A, Barnett J
     Safety, biodistribution and radiation dosimetry of the Arg-Gly-Asp peptide 99m Tc-maraciclatide in healthy volunteers.
     Nucl Med Commun. 2024;45:295-303.
     PubMed     Abstract available
     
     
     March 2024
140. GREEN A, Temsah P, Goldfarb L, Sanfolippo K, et al
     Evaluating appropriateness of 18F-fluciclovine PET/CT relative to standard of care imaging guidelines and the impact of ADT on positivity: a prospective study in 62 Veterans Administration patients at a single institution.
     Nucl Med Commun. 2024 Mar 22. doi: 10.1097/MNM.0000000000001836.
     PubMed     Abstract available
     
     
     
141. JALILIFAR M, Sadeghi M, Emami-Ardekani A, Geravand K, et al
     Quantifying partial volume effect in SPECT and planar imaging: optimizing region of interest for activity concentration estimation in different sphere sizes.
     Nucl Med Commun. 2024 Mar 20. doi: 10.1097/MNM.0000000000001835.
     PubMed     Abstract available
     
     
     
142. GONDHANE A, Verma P, Chandak A, Basu S, et al
     Prospective evaluation of 68Ga-NODAGA-RGD PET-CT in patients of carcinoma thyroid with thyroglobulin elevated negative radioiodine scintigraphy (TENIS) with a head-to-head comparison with FDG-PET/CT.
     Nucl Med Commun. 2024 Mar 6. doi: 10.1097/MNM.0000000000001828.
     PubMed     Abstract available
     
     
     
143. AL-NAHHAS A, Jawad ASM
     F-18-FDG PET-CT in investigating possible malignancy associated with rheumatic disease: beware of excessive radiation.
     Nucl Med Commun. 2024 Mar 6. doi: 10.1097/MNM.0000000000001834.
     PubMed    
     
     
     
144. PARKER JA, Tahir MM, Whitmarsh SR, Sarwar A, et al
     Free mebrofenin clearance.
     Nucl Med Commun. 2024;45:175-180.
     PubMed     Abstract available
     
     
     February 2024
145. FUKUSHIMA Y, Suzuki K, Kim M, Gu W, et al
     Evaluation of bone marrow invasion on the machine learning of 18F-FDG PET texture analysis in lower gingival squamous cell carcinoma.
     Nucl Med Commun. 2024 Feb 19. doi: 10.1097/MNM.0000000000001826.
     PubMed     Abstract available
     
     
     
146. DIZDAREVIC S, Mccready VR, Blower PJ, Voo SA, et al
     The British nuclear medicine research strategy - the framework.
     Nucl Med Commun. 2024 Feb 19. doi: 10.1097/MNM.0000000000001827.
     PubMed     Abstract available
     
     
     
147. PEI Y, Wang Z, Hao S, Tong Y, et al
     Analyzing the value of delayed 18F-FDG PET/CT images in diagnosing small colorectal cancer liver metastases in patients with hypothyroidism based on diagnostic accuracy and image standardized uptake value.
     Nucl Med Commun. 2024 Feb 19. doi: 10.1097/MNM.0000000000001825.
     PubMed     Abstract available
     
     
     
148. JONMARKER O, Nilsson T, Axelsson R, Ericson LH, et al
     [ 18 F]-PSMA-1007 PET imaging optimization and inter-rater reliability - a comparison of three different reconstructions read by four radiologists.
     Nucl Med Commun. 2024 Feb 5. doi: 10.1097/MNM.0000000000001823.
     PubMed     Abstract available
     
     
     
149. YANG H, Liu X, Wang L, Zhou W, et al
     18F-FDG PET/CT characteristics of IASLC grade 3 invasive adenocarcinoma and the value of 18F-FDG PET/CT for preoperative prediction: a new prognostication model.
     Nucl Med Commun. 2024 Feb 5. doi: 10.1097/MNM.0000000000001819.
     PubMed     Abstract available
     
     
     
150. WANG M, Peng M, Yang X, Zhang Y, et al
     Preoperative prediction of microsatellite instability status: development and validation of a pan-cancer PET/CT-based radiomics model.
     Nucl Med Commun. 2024 Feb 5. doi: 10.1097/MNM.0000000000001816.
     PubMed     Abstract available
     
     
     
151. PARGHANE RV, Suralkar T, Nikam D, Basu S, et al
     Evaluation of prostate-specific membrane antigen expression in locally advanced or metastatic breast carcinoma with 68Ga-PSMA-11 positron-emission tomography/computed tomography imaging for potential theranostics.
     Nucl Med Commun. 2024 Feb 5. doi: 10.1097/MNM.0000000000001820.
     PubMed     Abstract available
     
     
     
152. PUJATTI PB, Dos Santos JPG, Gomes ML, Cardoso MAS, et al
     A comparative study on the quality of in vivo labeled red blood cell radionuclide ventriculography images employing different freeze-dried reagents.
     Nucl Med Commun. 2024;45:155-160.
     PubMed     Abstract available
     
     
     January 2024
153. WECHALEKAR K, Hutt D, Quigley AM, Whelan C, et al
     Recommendations for good clinical practice for DPD bone scintigraphy for cardiac amyloidosis.
     Nucl Med Commun. 2024 Jan 26. doi: 10.1097/MNM.0000000000001796.
     PubMed    
     
     
     
154. VINJAMURI S, Pant V, Bomanji JB, Marengo M, et al
     Assessing nuclear medicine practices: a critical evaluation of QUANUM through a quality improvement perspective and its wider relevance.
     Nucl Med Commun. 2024 Jan 22. doi: 10.1097/MNM.0000000000001815.
     PubMed     Abstract available
     
     
     
155. OUCHI Y, Kishino T, Miyashita T, Mori T, et al
     Predictive value of local control by 4'-[methyl-11C]-thiotymidine PET volume parameters in p16-negative oropharyngeal, hypopharyngeal, and supraglottic squamous cell carcinoma.
     Nucl Med Commun. 2024 Jan 22. doi: 10.1097/MNM.0000000000001821.
     PubMed     Abstract available
     
     
     
156. THOMSON WH
     Using VARSKIN+v1.2 to estimate dose from direct skin contamination with radionuclides 223Ra, 212Pb and 225Ac; considerations for Nuclear Medicine staff and associated Personal Protective Equipment (PPE).
     Nucl Med Commun. 2024 Jan 19. doi: 10.1097/MNM.0000000000001808.
     PubMed     Abstract available
     
     
     
157. CONRAD TJ, Lau HX, Yerkovich ST, Alghamry A, et al
     Ventilation-perfusion scan for diagnosing pulmonary embolism: do chest x-rays matter?
     Nucl Med Commun. 2024 Jan 19. doi: 10.1097/MNM.0000000000001802.
     PubMed     Abstract available
     
     
     
158. ESEONU K, Oduoza U, Robinson P, Easty M, et al
     Bone scintigraphy with SPECT/CT in paediatric patients with neck and back pain in comparison with other imaging modalities: the experience of a tertiary paediatric referral centre.
     Nucl Med Commun. 2024 Jan 12. doi: 10.1097/MNM.0000000000001811.
     PubMed     Abstract available
     
     
     
159. MANAFI-FARID R, Mahini M, Mirshahvalad SA, Fallahi B, et al
     Diagnostic value of [68Ga]Ga-Pentixafor PET/CT in malignant melanoma: a pilot study.
     Nucl Med Commun. 2024 Jan 12. doi: 10.1097/MNM.0000000000001806.
     PubMed     Abstract available
     
     
     
160. KESIM S, Balaban Genc ZC, Soydemir E, Baltacioglu F, et al
     Evaluating therapeutic efficacy of extended shelf-life 90Y glass microspheres in transarterial radioembolization for colorectal cancer: a quantitative FDG PET/CT analysis.
     Nucl Med Commun. 2024 Jan 12. doi: 10.1097/MNM.0000000000001813.
     PubMed     Abstract available
     
     
     
161. BESTETTI A, Calabrese L, Parini V, Fornara C, et al
     Greater accuracy of radiomics compared to deep learning to discriminate normal subjects from patients with dementia: a whole brain 18FDG PET analysis.
     Nucl Med Commun. 2024 Jan 8. doi: 10.1097/MNM.0000000000001810.
     PubMed     Abstract available
     
     
     
162. LU Y, Kumbhar S, Liu Y, Vo NJ, et al
     Assessment of infant gonadal dose irradiated from urine-contaminated diapers during diuretic renal scintigraphy.
     Nucl Med Commun. 2024;45:45-50.
     PubMed     Abstract available
     
     
     
163. KAVURGACI S, Ozmen O, Tatci E, Soyler Y, et al
     Potential role of pre-treatment bone marrow SUVmean to liver SUVmean ratio (BM/L) and comparison of primary tumour FDG uptake with brain FDG uptake in predicting survival in limited-stage lung cancers.
     Nucl Med Commun. 2024;45:77-85.
     PubMed     Abstract available
     
     
     December 2023
164. ONAL C, Guler OC, Torun N, Reyhan M, et al
     Long-term assessment of clinical parameters and positron emission tomography parameters in predicting recurrence in uterine cervical cancer patients receiving definitive chemoradiotherapy.
     Nucl Med Commun. 2023 Dec 28. doi: 10.1097/MNM.0000000000001800.
     PubMed     Abstract available
     
     
     
165. AGAOGLU SANLI B, Duman E, Gulmez B, Aguloglu N, et al
     Evaluation of the effect of PET/CT Fluorodeoxyglucose inclusion on mortality and survival in operated thymoma patients.
     Nucl Med Commun. 2023 Dec 28. doi: 10.1097/MNM.0000000000001805.
     PubMed     Abstract available
     
     
     
166. AN S, Huang G, Yu X, Liu J, et al
     The added diagnostic value of 18F-FDG PET/CT radiomic analysis in multiple myeloma patients with negative visual analysis.
     Nucl Med Commun. 2023 Dec 28. doi: 10.1097/MNM.0000000000001809.
     PubMed     Abstract available
     
     
     
167. BABERWAL P, Sonavane S, Vimalnath KV, Chakravarty R, et al
     Normal physiological distribution and tumor localization of 64CuCl2 in different human malignancies along with semiquantitative scoring: a comparative evaluation with 18Fluorodeoxyglucose (18FDG) PET-CT.
     Nucl Med Commun. 2023 Dec 28. doi: 10.1097/MNM.0000000000001804.
     PubMed     Abstract available
     
     
     
168. WU KC, Chen SW, Hsieh TC, Yen KY, et al
     Early prediction of distant metastasis in patients with uterine cervical cancer treated with definitive chemoradiotherapy by deep learning using pretreatment [18F]fluorodeoxyglucose positron emission tomography/computed tomography.
     Nucl Med Commun. 2023 Dec 27. doi: 10.1097/MNM.0000000000001799.
     PubMed     Abstract available
     
     
     
169. JENA SR, Watts A, Aggarwal P, Bachhal V, et al
     68Ga-Pentixafor PET/CT for in-vivo mapping of CXCR4 receptors as potential radiotheranostic targets in soft tissue and bone sarcoma: preliminary results.
     Nucl Med Commun. 2023 Dec 27. doi: 10.1097/MNM.0000000000001803.
     PubMed     Abstract available
     
     
     
170. XU M, Gu B, Zhang J, Xu X, et al
     Differentiation of cancer of unknown primary and lymphoma in head and neck metastatic poorly differentiated cancer using 18F-FDG PET/CT tumor metabolic heterogeneity index.
     Nucl Med Commun. 2023 Dec 14. doi: 10.1097/MNM.0000000000001797.
     PubMed     Abstract available
     
     
     
171. SHARMA A, Garg A, Singh M, Sharma MC, et al
     Metabolic imaging in recurrent gliomas: comparative performance of 18F-FDOPA, 18F-fluorocholine and 18F-FDG PET/CT.
     Nucl Med Commun. 2023 Dec 14. doi: 10.1097/MNM.0000000000001795.
     PubMed     Abstract available
     
     
     
172. 
     British Nuclear Medicine Society Autumn Meeting 2023.
     Nucl Med Commun. 2023;44:1191-1214.
     PubMed    
     
     
     
173. MCMEEKIN HJ, Peters AM, Burniston MT, Vadrucci M, et al
     Quantitative lymphoscintigraphy of the lower limbs for the diagnosis of phlebolymphoedema.
     Nucl Med Commun. 2023;44:1080-1086.
     PubMed     Abstract available
     
     
     
174. SAGAR S, Kaushik P, Phulia A, Khan D, et al
     Diagnostic accuracy of RBC scintigraphy and CTA for detection of patients with suspected lower gastrointestinal bleeding: a systematic review and meta-analysis.
     Nucl Med Commun. 2023;44:1074-1079.
     PubMed     Abstract available
     
     
     
175. MARTINEAU PJ, Pelletier-Galarneau M, Slomka P, Goertzen AL, et al
     Optimizing stress-only myocardial perfusion imaging: a clinical prediction model to improve patient selection.
     Nucl Med Commun. 2023;44:1087-1093.
     PubMed     Abstract available
     
     
     November 2023
176. KAUR K, Nagi S, Satapathy S, Aggarwal P, et al
     Estimation of absorbed dose to salivary glands in mCRPC patients undergoing 177 Lu- PSMA-617 radioligand therapy using quantitative SPECT-CT at single time point: a single-center feasibility study.
     Nucl Med Commun. 2023 Nov 20. doi: 10.1097/MNM.0000000000001792.
     PubMed     Abstract available
     
     
     
177. KALRA S, Tripathi M, Tripathi M, Sonar RS, et al
     Role of FDG PET/CT in definitive and presumed autoimmune encephalitis.
     Nucl Med Commun. 2023 Nov 20. doi: 10.1097/MNM.0000000000001790.
     PubMed     Abstract available
     
     
     
178. VALKEMA MJ, de Lussanet de la Sabloniere QG, Valkema R, Thomeer MGJ, et al
     18F-FDG PET/MRI for restaging esophageal cancer after neoadjuvant chemoradiotherapy.
     Nucl Med Commun. 2023 Nov 20. doi: 10.1097/MNM.0000000000001793.
     PubMed     Abstract available
     
     
     October 2023
179. KIM SJ, Park CY, Kwon H, Kim YH, et al
     Evaluation of adrenal masses using 18F-FDOPA PET/CT in patients suspected with pheochromocytoma.
     Nucl Med Commun. 2023 Oct 30. doi: 10.1097/MNM.0000000000001781.
     PubMed     Abstract available
     
     
     
180. COOK GJ, Dickson J, Chicklore S, Dempsey M, et al
     BNMS UK PET standards.
     Nucl Med Commun. 2023 Oct 30. doi: 10.1097/MNM.0000000000001779.
     PubMed    
     
     
     
181. PANAGIOTIDIS E, Papachristou K, Makridou A, Zoglopitou LA, et al
     Review of artificial intelligence clinical applications in Nuclear Medicine.
     Nucl Med Commun. 2023 Oct 30. doi: 10.1097/MNM.0000000000001786.
     PubMed     Abstract available
     
     
     
182. SAGARA H, Inoue K, Yaku H, Ohsawa A, et al
     A new simpler image quality index based on body size for FDG-PET/CT.
     Nucl Med Commun. 2023 Oct 30. doi: 10.1097/MNM.0000000000001787.
     PubMed     Abstract available
     
     
     
183. HERNANDEZ MC, Yazaki P, Mortimer JE, Yamauchi D, et al
     Pilot study of HER2 targeted 64Cu-DOTA-tagged PET imaging in gastric cancer patients.
     Nucl Med Commun. 2023 Oct 30. doi: 10.1097/MNM.0000000000001761.
     PubMed     Abstract available
     
     
     
184. MILOSEVIC A, Styczen H, Haubold J, Kessler L, et al
     Correlation of the apparent diffusion coefficient with the standardized uptake value in meningioma of the skull plane using [68]Ga-DOTATOC PET/MRI.
     Nucl Med Commun. 2023 Oct 12. doi: 10.1097/MNM.0000000000001774.
     PubMed     Abstract available
     
     
     
185. WANG F, Yuan H, Lv J, Han X, et al
     Stress-only versus rest-stress SPECT MPI in the detection and diagnosis of myocardial ischemia and infarction by machine learning.
     Nucl Med Commun. 2023 Oct 12. doi: 10.1097/MNM.0000000000001782.
     PubMed     Abstract available
     
     
     
186. ZHAO M, Zan K, Cui X, Chai L, et al
     Investigation of the quarter-dose 18F-FDG total-body PET in routine clinical practice and its clinical value.
     Nucl Med Commun. 2023 Oct 12. doi: 10.1097/MNM.0000000000001777.
     PubMed     Abstract available
     
     
     
187. RAJU S, Sharma A, Kumar S, Seth A, et al
     Impact of forced diuresis at two different time points on pelvic imaging in prostatic carcinoma with 68Ga-PSMA PET/CT.
     Nucl Med Commun. 2023 Oct 5. doi: 10.1097/MNM.0000000000001771.
     PubMed     Abstract available
     
     
     
188. PANAGIOTIDIS E, Fragkiadaki V, Papathanasiou N, Kypraios C, et al
     Comparison of 18F-PSMA-1007 and 18F-Choline PET/CT in prostate cancer patients with biochemical recurrence: a phase 3, prospective, multicenter, randomized study.
     Nucl Med Commun. 2023 Oct 2. doi: 10.1097/MNM.0000000000001770.
     PubMed     Abstract available
     
     
     
189. CISTARO A, Quartuccio N, Piccardo A, Meo G, et al
     Brain positron emission tomography in idiopathic normal-pressure hydrocephalus: new 18F-fluorodeoxyglucose pattern in a long-known syndrome.
     Nucl Med Commun. 2023 Oct 2. doi: 10.1097/MNM.0000000000001763.
     PubMed     Abstract available
     
     
     
190. MCCREADY R, Dizdarevic S
     Acronyms in Nuclear Medicine (AINM).
     Nucl Med Commun. 2023;44:926.
     PubMed    
     
     
     
191. HAIDAR M, Jazra D, Kassas M
     Challenging false positive findings in 68Ga-FAPI PET: insights from a clinical case.
     Nucl Med Commun. 2023;44:924-926.
     PubMed    
     
     
     
192. AKTAS A, Baskin E, Gencoglu EA, Colak T, et al
     Comparison of parathyroid scintigraphy findings in pediatric and adult patients with secondary hyperparathyroidism.
     Nucl Med Commun. 2023;44:860-863.
     PubMed     Abstract available
     
     
     
193. GHAEDIAN T, Abdinejad M, Nasrollahi H, Ghaedian M, et al
     Comparing the role of 99m Tc-HYNIC-PSMA-11 and 99m Tc-MDP scintigraphy for the initial staging of intermediate to high-risk prostate cancer.
     Nucl Med Commun. 2023;44:864-869.
     PubMed     Abstract available
     
     
     
194. MISSIR E, Begley P, Jessop M, Singh N, et al
     Quantitative [123]I-Ioflupane DaTSCAN single-photon computed tomography-computed tomography in Parkinsonism.
     Nucl Med Commun. 2023;44:843-853.
     PubMed     Abstract available
     
     
     September 2023
195. LI P, Zhang Y, Xu T, Zhu J, et al
     Sensitivities evaluation of five radiopharmaceuticals in four common medullary thyroid carcinoma metastatic sites on PET/CT: a network meta-analysis and systematic review.
     Nucl Med Commun. 2023 Sep 29. doi: 10.1097/MNM.0000000000001773.
     PubMed     Abstract available
     
     
     
196. LUE KH, Chen YH, Chu SC, Chang BS, et al
     A comparison of 18F-FDG PET-based radiomics and deep learning in predicting regional lymph node metastasis in patients with resectable lung adenocarcinoma: a cross-scanner and temporal validation study.
     Nucl Med Commun. 2023 Sep 21. doi: 10.1097/MNM.0000000000001776.
     PubMed     Abstract available
     
     
     
197. MCQUAID SJ
     The impact of total body PET.
     Nucl Med Commun. 2023 Sep 21. doi: 10.1097/MNM.0000000000001772.
     PubMed    
     
     
     
198. BIN ESSA N, Kaplar Z, Balaji N, Alduraibi A, et al
     PET/CT in treatment response assessment in lung cancer. When should it be recommended?
     Nucl Med Commun. 2023 Sep 14. doi: 10.1097/MNM.0000000000001757.
     PubMed     Abstract available
     
     
     
199. WAMASING N, Nakamura S, Watanabe H, Kuribayashi A, et al
     Potential of preoperative fluorodeoxyglucose-positron emission tomography/computed tomography to diagnose contralateral lymph node metastases in patients with oral cancer.
     Nucl Med Commun. 2023 Sep 14. doi: 10.1097/MNM.0000000000001765.
     PubMed     Abstract available
     
     
     
200. WANG H, Xie X, Duan Y, Chai L, et al
     Rabbit systemic glucose metabolism map by total-body dynamic PET/CT technology.
     Nucl Med Commun. 2023 Sep 14. doi: 10.1097/MNM.0000000000001767.
     PubMed     Abstract available
     
     
     
201. HAIDAR M, Kassas M, Chehade F, Chahinian R, et al
     The role of 18F-FDG-PET/CT in the management of differentiated thyroid cancer.
     Nucl Med Commun. 2023 Sep 14. doi: 10.1097/MNM.0000000000001758.
     PubMed     Abstract available
     
     
     
202. GHOSH S, Agrawal A, Rangarajan V, Choudhury S, et al
     Evaluation of post-chemotherapy residual seminomatous masses by 18F-fluorodeoxyglucose PET/CT using tumor-to-liver ratio - conundrum or solution?
     Nucl Med Commun. 2023 Sep 14. doi: 10.1097/MNM.0000000000001762.
     PubMed     Abstract available
     
     
     
203. IRWIN AG
     Scientific support for nuclear medicine.
     Nucl Med Commun. 2023 Sep 14. doi: 10.1097/MNM.0000000000001754.
     PubMed     Abstract available
     
     
     
204. DANG S, Shivdasani D, Pereira M, Singh N, et al
     Evaluation of treatment response by Hopkins criteria on18F FDG PET-CT in patients of non-small cell lung cancer and its comparison with PERCIST response criteria.
     Nucl Med Commun. 2023 Sep 4. doi: 10.1097/MNM.0000000000001756.
     PubMed     Abstract available
     
     
     
205. ROGEAU A, Lilburn DML, Kaplar Z, Anderson C, et al
     Identifying and troubleshooting the pitfalls of ictal/interictal brain perfusion SPECT studies.
     Nucl Med Commun. 2023 Sep 4. doi: 10.1097/MNM.0000000000001755.
     PubMed     Abstract available
     
     
     
206. DONG Y, Sun P, Wu H, Zhong J, et al
     PET/CT imaging fibroblast activation protein in initial colorectal cancer: compared to 18F-FDG PET/CT.
     Nucl Med Commun. 2023 Sep 4. doi: 10.1097/MNM.0000000000001751.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Nuclear Medicine is free of charge.